Determinants and Changes Associated with Aldosterone Breakthrough after Angiotensin II Receptor Blockade in Patients with Type 2 Diabetes with Overt Nephropathy-Reference-Cited by-同舟云学术

Determinants and Changes Associated with Aldosterone Breakthrough after Angiotensin II Receptor Blockade in Patients with Type 2 Diabetes with Overt Nephropathy

Published:2013-08-08 Issue:10 Volume:8 Page:1694-1701
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Moranne Olivier,Bakris George,Fafin Coraline,Favre Guillaume,Pradier Christian,Esnault Vincent L.M.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference31 articles.

1. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

2. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease

3. Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.;Jafar;Ann Intern Med,2002

4. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

5. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes;BMC Nephrology;2024-08-01

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease;International Journal of Molecular Sciences;2024-01-10

4. New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review;Pharmaceutics;2022-07-28

5. Remission inductive efficacy of the combination of ARB , MRA , and saireito for nephrotic syndrome of membranous nephropathy;Traditional & Kampo Medicine;2022-04-29